Cryoport, Inc. Logo

Cryoport, Inc.

CYRX

(0.8)
Stock Price

8,73 USD

-7.08% ROA

-18.69% ROE

-15.69x PER

Market Cap.

732.496.952,00 USD

76.96% DER

0% Yield

-42.69% NPM

Cryoport, Inc. Stock Analysis

Cryoport, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Cryoport, Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's PBV ratio (1.22x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

2 DER

The stock has a reasonable amount of debt compared to its ownership (81%), suggesting a balanced financial position and a moderate level of risk.

3 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

4 ROE

Negative ROE (-6.98%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (-5.64%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

7 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (-227) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Cryoport, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Cryoport, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Cryoport, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Cryoport, Inc. Revenue
Year Revenue Growth
2003 271.429
2004 152.298 -78.22%
2005 67.103 -126.96%
2006 83.564 19.7%
2007 35.124 -137.91%
2008 117.956 70.22%
2009 475.504 75.19%
2010 555.637 14.42%
2011 1.100.539 49.51%
2012 2.659.943 58.63%
2013 3.935.320 32.41%
2015 7.678.816 48.75%
2016 11.954.267 35.77%
2017 19.626.453 39.09%
2018 33.941.900 42.18%
2019 78.696.000 56.87%
2020 222.608.000 64.65%
2021 237.277.000 6.18%
2022 224.628.000 -5.63%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Cryoport, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2003 98.698
2004 254.487 61.22%
2005 87.857 -189.66%
2006 166.227 47.15%
2007 297.378 44.1%
2008 284.847 -4.4%
2009 449.129 36.58%
2010 491.849 8.69%
2011 425.446 -15.61%
2012 409.111 -3.99%
2013 352.580 -16.03%
2015 598.106 41.05%
2016 1.205.692 50.39%
2017 1.840.443 34.49%
2018 3.740.642 50.8%
2019 9.484.000 60.56%
2020 16.843.000 43.69%
2021 15.722.000 -7.13%
2022 20.608.000 23.71%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Cryoport, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2003 622.797
2004 1.023.088 39.13%
2005 1.899.228 46.13%
2006 2.550.778 25.54%
2007 2.387.287 -6.85%
2008 3.312.635 27.93%
2009 4.320.461 23.33%
2010 6.106.006 29.24%
2011 5.411.728 -12.83%
2012 5.106.219 -5.98%
2013 6.409.381 20.33%
2015 6.449.196 0.62%
2016 7.420.837 13.09%
2017 9.798.793 24.27%
2018 17.465.191 43.9%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Cryoport, Inc. EBITDA
Year EBITDA Growth
2003 -855.294
2004 -1.352.174 36.75%
2005 -1.985.072 31.88%
2006 -1.675.822 -18.45%
2007 -3.081.611 45.62%
2008 -4.038.979 23.7%
2009 -5.336.026 24.31%
2010 -7.079.709 24.63%
2011 -5.930.499 -19.38%
2012 -18.800.220 68.46%
2013 -5.597.298 -235.88%
2015 -8.398.677 33.36%
2016 -7.878.165 -6.61%
2017 -8.566.984 8.04%
2018 -16.902.980 49.32%
2019 -30.939.000 45.37%
2020 -20.652.000 -49.81%
2021 -37.426.000 44.82%
2022 -79.872.000 53.14%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Cryoport, Inc. Gross Profit
Year Gross Profit Growth
2003 -228.221
2004 -163.352 -39.71%
2005 -109.836 -48.72%
2006 -302.807 63.73%
2007 -511.028 40.75%
2008 -599.754 14.79%
2009 -827.484 27.52%
2010 -836.823 1.12%
2011 -487.284 -71.73%
2012 436.955 211.52%
2013 1.168.929 62.62%
2015 3.101.423 62.31%
2016 5.966.433 48.02%
2017 10.240.265 41.74%
2018 17.351.656 40.98%
2019 36.334.000 52.24%
2020 96.577.000 62.38%
2021 103.873.000 7.02%
2022 97.064.000 -7.01%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Cryoport, Inc. Net Profit
Year Net Profit Growth
2003 -1.038.110
2004 -1.522.101 31.8%
2005 -2.326.259 34.57%
2006 -4.564.054 49.03%
2007 -16.705.151 72.68%
2008 -5.651.561 -195.58%
2009 -6.152.278 8.14%
2010 -7.832.928 21.46%
2011 -6.382.433 -22.73%
2012 -19.565.426 67.38%
2013 -7.026.913 -178.44%
2015 -13.113.220 46.41%
2016 -7.899.001 -66.01%
2017 -9.555.601 17.34%
2018 -18.331.479 47.87%
2019 -32.693.000 43.93%
2020 -275.528.000 88.13%
2021 -37.333.000 -638.03%
2022 -53.076.000 29.66%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Cryoport, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2003 -6
2004 -6 -20%
2005 -8 37.5%
2006 -13 33.33%
2007 -45 73.33%
2008 -13 -275%
2009 -5 -140%
2010 -3 -66.67%
2011 -2 -200%
2012 -4 75%
2013 -1 -300%
2015 -1 0%
2016 0 0%
2017 0 0%
2018 -1 0%
2019 -1 0%
2020 -6 100%
2021 -1 0%
2022 -1 100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Cryoport, Inc. Free Cashflow
Year Free Cashflow Growth
2003 -1.032.995
2004 -1.198.012 13.77%
2005 -710.259 -68.67%
2006 -2.002.778 64.54%
2007 -2.694.829 25.68%
2008 -3.002.233 10.24%
2009 -5.276.861 43.11%
2010 -7.168.195 26.39%
2011 -4.963.826 -44.41%
2012 -4.519.545 -9.83%
2013 -4.197.832 -7.66%
2015 -6.786.802 38.15%
2016 -5.383.703 -26.06%
2017 -6.312.983 14.72%
2018 -6.733.309 6.24%
2019 -24.535.000 72.56%
2020 -16.881.000 -45.34%
2021 -26.048.000 35.19%
2022 -382.000 -6718.85%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Cryoport, Inc. Operating Cashflow
Year Operating Cashflow Growth
2003 -1.018.116
2004 -1.155.962 11.92%
2005 -710.259 -62.75%
2006 -1.820.250 60.98%
2007 -2.586.470 29.62%
2008 -2.853.359 9.35%
2009 -4.811.411 40.7%
2010 -6.780.134 29.04%
2011 -4.785.144 -41.69%
2012 -4.380.659 -9.23%
2013 -4.127.702 -6.13%
2015 -5.718.876 27.82%
2016 -3.583.126 -59.61%
2017 -3.352.380 -6.88%
2018 -1.323.860 -153.23%
2019 -14.866.000 91.09%
2020 8.126.000 282.94%
2021 -1.851.000 539.01%
2022 -382.000 -384.55%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Cryoport, Inc. Capital Expenditure
Year Capital Expenditure Growth
2003 14.879
2004 42.050 64.62%
2005 0 0%
2006 182.528 100%
2007 108.359 -68.45%
2008 148.874 27.21%
2009 465.450 68.02%
2010 388.061 -19.94%
2011 178.682 -117.18%
2012 138.886 -28.65%
2013 70.130 -98.04%
2015 1.067.926 93.43%
2016 1.800.577 40.69%
2017 2.960.603 39.18%
2018 5.409.449 45.27%
2019 9.669.000 44.05%
2020 25.007.000 61.33%
2021 24.197.000 -3.35%
2022 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Cryoport, Inc. Equity
Year Equity Growth
2003 -1.180.035
2004 -2.150.036 45.12%
2005 -2.287.832 6.02%
2006 -181 -1263895.58%
2007 -4.775.904 100%
2008 -914.575 -422.2%
2009 5.948.409 115.38%
2010 3.729.520 -59.5%
2011 -2.063.275 280.76%
2012 -2.304.495 10.47%
2013 -416.299 -453.57%
2015 5.680.402 107.33%
2016 17.886.766 68.24%
2017 38.546.565 53.6%
2018 126.281.348 69.48%
2019 382.698.000 67%
2020 641.828.000 40.37%
2021 555.838.000 -15.47%
2022 537.528.000 -3.41%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Cryoport, Inc. Assets
Year Assets Growth
2003 1.080.428
2004 293.505 -268.11%
2005 483.687 39.32%
2006 3.460.889 86.02%
2007 1.572.556 -120.08%
2008 4.776.546 67.08%
2009 11.031.467 56.7%
2010 6.213.599 -77.54%
2011 1.755.797 -253.89%
2012 1.709.950 -2.68%
2013 2.606.649 34.4%
2015 8.111.933 67.87%
2016 20.264.111 59.97%
2017 56.620.097 64.21%
2018 135.872.538 58.33%
2019 552.405.000 75.4%
2020 1.112.970.000 50.37%
2021 1.038.746.000 -7.15%
2022 1.000.656.000 -3.81%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Cryoport, Inc. Liabilities
Year Liabilities Growth
2003 2.260.463
2004 2.443.541 7.49%
2005 2.771.519 11.83%
2006 3.461.070 19.92%
2007 6.348.460 45.48%
2008 5.691.121 -11.55%
2009 5.083.058 -11.96%
2010 2.484.079 -104.63%
2011 3.819.072 34.96%
2012 4.014.445 4.87%
2013 3.022.948 -32.8%
2015 2.431.531 -24.32%
2016 2.377.345 -2.28%
2017 18.073.532 86.85%
2018 9.591.190 -88.44%
2019 169.707.000 94.35%
2020 471.142.000 63.98%
2021 482.908.000 2.44%
2022 463.128.000 -4.27%

Cryoport, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
4.83
Net Income per Share
-0.95
Price to Earning Ratio
-15.69x
Price To Sales Ratio
3.1x
POCF Ratio
367.27
PFCF Ratio
-26.5
Price to Book Ratio
1.36
EV to Sales
4.6
EV Over EBITDA
-22.88
EV to Operating CashFlow
545.53
EV to FreeCashFlow
-39.32
Earnings Yield
-0.06
FreeCashFlow Yield
-0.04
Market Cap
0,73 Bil.
Enterprise Value
1,09 Bil.
Graham Number
15.36
Graham NetNet
1.01

Income Statement Metrics

Net Income per Share
-0.95
Income Quality
-0.04
ROE
-0.08
Return On Assets
-0.1
Return On Capital Employed
-0.07
Net Income per EBT
1
EBT Per Ebit
1.53
Ebit per Revenue
-0.28
Effective Tax Rate
-0

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.08
Stock Based Compensation to Revenue
0.09
Gross Profit Margin
0.41
Operating Profit Margin
-0.28
Pretax Profit Margin
-0.43
Net Profit Margin
-0.43

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
-0.13
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.04
Free CashFlow per Share
-0.57
Capex to Operating CashFlow
-14.88
Capex to Revenue
-0.13
Capex to Depreciation
-1.13
Return on Invested Capital
-0.06
Return on Tangible Assets
-0.07
Days Sales Outstanding
65.83
Days Payables Outstanding
0
Days of Inventory on Hand
79.27
Receivables Turnover
5.54
Payables Turnover
0
Inventory Turnover
4.6
Capex per Share
-0.61

Balance Sheet

Cash per Share
9,53
Book Value per Share
10,99
Tangible Book Value per Share
4
Shareholders Equity per Share
10.99
Interest Debt per Share
8.57
Debt to Equity
0.77
Debt to Assets
0.41
Net Debt to EBITDA
-7.46
Current Ratio
12.23
Tangible Asset Value
0,20 Bil.
Net Current Asset Value
0,09 Bil.
Invested Capital
0.77
Working Capital
0,50 Bil.
Intangibles to Total Assets
0.34
Average Receivables
0,04 Bil.
Average Payables
0,01 Bil.
Average Inventory
28962500
Debt to Market Cap
0.56

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Cryoport, Inc. Dividends
Year Dividends Growth

Cryoport, Inc. Profile

About Cryoport, Inc.

Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.

CEO
Mr. Jerrell W. Shelton
Employee
1.019
Address
112 Westwood Place
Brentwood, 37027

Cryoport, Inc. Executives & BODs

Cryoport, Inc. Executives & BODs
# Name Age
1 Mr. Bret Bollinger
Vice President & Chief Innovation Officer
70
2 Mr. Edward J. Zecchini
Senior Vice President and Chief Digital & Technology Officer
70
3 Mr. Thomas J. Heinzen
Vice President of Corporate Development & Investor Relations
70
4 Mr. Jerrell W. Shelton
Chairman, President & Chief Executive Officer
70
5 Mr. Phil Wilson
Chief Operating Officer of Cryoport Systems, LLC
70
6 Mr. Tony Ippolito
Vice President, General Counsel & Corporate Secretary
70
7 Ms. Kylie A. Crowe
Vice President of Global Human Resources & Organizational Development
70
8 Mr. Robert S. Stefanovich MS
Chief Financial Officer & Treasurer
70
9 Dr. Mark W. Sawicki Ph.D.
Chief Scientific Officer
70

Cryoport, Inc. Competitors

CareDx, Inc Logo
CareDx, Inc

CDNA

(1.0)
Axonics, Inc. Logo
Axonics, Inc.

AXNX

(1.8)
Natera, Inc. Logo
Natera, Inc.

NTRA

(1.2)